Source: NCID Alert ( 5 August 2024) & WHO Press Conference ( 7 August 2024)
The Department of Health has urged continued public vigilance against mpox following the detection of two new cases in Gauteng and KwaZulu-Natal. These cases, the first in 26 days, bring South Africa's total to 24 confirmed cases, with 12 in Gauteng, 11 in KwaZulu-Natal, and one in the Western Cape.
The recent cases involve a 36-year-old man in KwaZulu-Natal with no travel history and a 20-year-old man in Gauteng who had traveled to Peru, a country with high mpox rates. The Department is conducting contact tracing and monitoring in affected communities, urging cooperation to prevent further transmission. The Department has confirmed that a new batch of the antiviral drug Tecovirimat has been received from the World Health Organization to support the ongoing response.
This comes as the World Health Organization (WHO) has called an emergency meeting in response to a surge in mpox cases in the Democratic Republic of Congo (DRC). Nearly 27,000 cases and approximately 1,100 deaths, many among children, have been reported in the DRC since last September, with the virus now spreading to neighboring countries like Burundi, Kenya, Rwanda, and Uganda.
WHO Director-General Tedros Adhanom Ghebreyesus announced that the meeting will convene under the International Health Regulations to determine if the outbreak constitutes a Public Health Emergency of International Concern (PHEIC), the highest level of alert WHO can issue. The date for the meeting has yet to be set, but WHO is treating the situation with urgency due to the potential for further international spread.
Access more articles related to Mpox
11 July 2024 | DoH confirms two new cases, bringing the total cases in the latest outbreak to twenty-two
27 June 2024 | Department of Health issues Mpox update
14 June 2024 | Department of Health urges patients to adhere to treatments as Mpox cases increase
14 May 2024 | Calls for vigilance as new case of Monkeypox confirmed
Access Original Press Release
5 August 2024 | Health Department Urges Vigilance as Mpox Cases Resurge
Disclaimer
This article is compiled from various resources researched and compiled by the contributor. It is in no way presented as an original work. Every effort has been made to correctly attribute quotes and content. Where possible all information has been independently verified. The Medical Education Network bears no responsibility for any inaccuracies which may occur from the use of third-party sources. If you have any queries regarding this article contact us
Fact-checking Policy
The Medical Education Network makes every effort to review and fact-check the articles used as source material in our summaries and original material. We have strict guidelines in relation to the publications we use as our source data, favouring peer-reviewed research wherever possible. Every effort is made to ensure that the information contained here is an accurate reflection of the original material. Should you find inaccuracies, out of date content or have any additional issues with our articles, please make use of the contact us form to notify us.